MDT and patient perspectives on GLP-1 RA therapy and emerging incretin-based dual agonists in T2D and obesity
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team and a patient explore the use of GLP-1 RA therapy to treat T2D and obesity, including observations from a patient’s perspective, and consider the evidence for incretin-based dual agonists in development
The multidisciplinary team and patient
Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA
Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA
Patient: Ms Brittany Jones, Atlanta, GA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.